NEW YORK--(BUSINESS WIRE)--May 22, 2006--The Epilepsy Research Foundation, a collaboration of several non-profit organizations and a supporting organization of the Epilepsy Foundation and the Epilepsy Therapy Development Project, today announced two recipients of translational research funds totaling $190,000 for work to advance a promising and potent new epilepsy drug, and for the development of an imaging contrast agent that for the first time will make epileptogenic tissue visible to MRI.
